Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
November 1988

Recombinant Human Tumor Necrosis Factor Increases Granulocyte Cell-Surface Complement Receptor Number

Author Affiliations

From the Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston.

Arch Surg. 1988;123(11):1333-1336. doi:10.1001/archsurg.1988.01400350047006

• Exposure of human buffy-coat granulocytes to tumor necrosis factor (TNF) produced cellular activation as indicated by an increase in the neutrophil and monocyte cell-surface number of C3b receptors (measured by indirect immunofluorescence). The degree of receptor increase depended on the dose of TNF from 25 to 1250 pg/mL. Results of kinetic analysis confirmed this response: TNF, 250 pg/mL, caused an increase in the C3b receptor number within ten minutes. Purified neutrophils exhibited a similar increase in cell-surface C3b receptors dependent on the concentration of TNF. Tumor necrosis factor could be a mediator of granulocyte activation in patients.

(Arch Surg 1988;123:1333-1336)